Apolizumab, CAS 267227-08-7

Product Description: Apolizumab (Hu1D10) is a humanized monoclonal anti-Human leukocyte antigen-DR beta-chain antibody. Apolizumab can mediate apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Thomas S Lin, et al. A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia. Leuk Lymphoma. 2009 Dec;50(12):1958-63./[2]Matthew L. Hill DO, et al. In Vitro Activity of the Humanized Anti-HLA-DR Antibodies KRN848 and Apolizumab in Non-Hodgkins Lymphoma Cell Lines. Volume 106, Issue 11, 16 November 2005, Page 4826.

CAS Number: 267227-08-7

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Apoptosis

• SKU: MEXHY-P99442-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99442-5
• Green Labware: No
• Package Unit: 5mg
• Quantity Unit: STK